Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome

A pregnant young woman with a severe migraine is prescribed candesartan, an angiotensin II type 1 receptor antagonist (AT II antagonists). This has a positive effect—except for severe maldevelopment of her fetus. There is an increase in the use of the fetotoxic drugs, AT II antagonists and angiotens...

Descripción completa

Detalles Bibliográficos
Autor principal: Haaland, Kirsti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2010
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452282/
https://www.ncbi.nlm.nih.gov/pubmed/20063032
http://dx.doi.org/10.1007/s10194-009-0182-7
_version_ 1782244458365976576
author Haaland, Kirsti
author_facet Haaland, Kirsti
author_sort Haaland, Kirsti
collection PubMed
description A pregnant young woman with a severe migraine is prescribed candesartan, an angiotensin II type 1 receptor antagonist (AT II antagonists). This has a positive effect—except for severe maldevelopment of her fetus. There is an increase in the use of the fetotoxic drugs, AT II antagonists and angiotensin-converting enzyme inhibitors, as prophylactic treatment of migraines, in addition to their use as hypertensives.
format Online
Article
Text
id pubmed-3452282
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-34522822012-11-29 Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome Haaland, Kirsti J Headache Pain Brief Report A pregnant young woman with a severe migraine is prescribed candesartan, an angiotensin II type 1 receptor antagonist (AT II antagonists). This has a positive effect—except for severe maldevelopment of her fetus. There is an increase in the use of the fetotoxic drugs, AT II antagonists and angiotensin-converting enzyme inhibitors, as prophylactic treatment of migraines, in addition to their use as hypertensives. Springer Milan 2010-01-09 2010-04 /pmc/articles/PMC3452282/ /pubmed/20063032 http://dx.doi.org/10.1007/s10194-009-0182-7 Text en © Springer-Verlag 2010
spellingShingle Brief Report
Haaland, Kirsti
Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
title Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
title_full Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
title_fullStr Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
title_full_unstemmed Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
title_short Angiotensin II receptor antagonists against migraine in pregnancy: fatal outcome
title_sort angiotensin ii receptor antagonists against migraine in pregnancy: fatal outcome
topic Brief Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452282/
https://www.ncbi.nlm.nih.gov/pubmed/20063032
http://dx.doi.org/10.1007/s10194-009-0182-7
work_keys_str_mv AT haalandkirsti angiotensiniireceptorantagonistsagainstmigraineinpregnancyfataloutcome

Ejemplares similares